ESC 365 - A STEMI patient on an oral anticoagulant due to a mitral valve prosthesis. - How to implement the Guidelines.

ESC Premium Access

A STEMI patient on an oral anticoagulant due to a mitral valve prosthesis. - How to implement the Guidelines.

Session: Managing STEMI in patients on oral anticoagulation

Topic: Cardiovascular Pharmacotherapy

Event: ESC Congress 2018

Congress Presentation

7 more presentations in this session

Case 1: a STEMI patient on an oral anticoagulant due to a mitral valve prosthesis.

Speaker: Doctor R. Helseth (Oslo, NO)

A STEMI patient on an oral anticoagulant due to a mitral valve prosthesis. - What do the Guidelines say?

Speaker: Professor S. James (Uppsala, SE)

A STEMI patient on an oral anticoagulant due to a mitral valve prosthesis. - Conclusion and take home message.

Speaker: Doctor G. Georgiou (Nicosia, CY)

Case 2: A patient stented for STEMI who develops paroxysmal atrial fibrillation.

Speaker: Doctor A. Awoyemi (Oslo, NO)

A patient stented for STEMI who develops paroxysmal atrial fibrillation - What do the Guidelines say?

Speaker: Professor B. Ibanez (Madrid, ES)

Access the full session

Managing STEMI in patients on oral anticoagulation

Speakers: Doctor R. Helseth, Professor S. James, Doctor G. Georgiou, Doctor A. Awoyemi, Professor B. Ibanez

About the event

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress

Related content

Open Access

Mode of intervention in aortic stenosis.

28 August 2021

Open Access

Timing and indication of intervention in asymptomatic patients with valvular heart disease.

28 August 2021

ESC Premium Access

Changes in EPA and DHA during supplementation with Omega-3 fatty acids and incident cardiovascular events: secondary analysis from the OMEMI trial

27 August 2021

ESC 365 is supported by